- Home
- PTIX vs HSDT Comparison
PTIX vs HSDT Comparison
Compare PTIX & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTIX | HSDT |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 165.6M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTIX | HSDT |
|---|---|---|
| Price | $1.66 | $3.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 103.8K | ★ 713.8K |
| Earning Date | 11-26-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $941,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $75.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 87.45 |
| 52 Week Low | $1.46 | $2.83 |
| 52 Week High | $14.28 | $1,200.00 |
Technical Indicators
Market Signals| Indicator | PTIX | HSDT |
|---|---|---|
| Relative Strength Index (RSI) | 33.67 | 34.42 |
| Support Level | $1.46 | $3.83 |
| Resistance Level | $1.70 | $4.32 |
| Average True Range (ATR) | 0.18 | 0.41 |
| MACD | -0.00 | 0.19 |
| Stochastic Oscillator | 20.65 | 22.13 |
Price Performance
Historical ComparisonAbout PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.